CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- 4 Open-market sale Executive VP & CFO sold 16,310 shares at an average $629.05 ($10,259,809)
- 4 Grant or award Director acquired 10 shares (grant or award)
- 4 Grant or award Director acquired 36 shares (grant or award)
- 4 Grant or award Director acquired 30 shares (grant or award)
- 4 Exercise or conversion Director acquired 1,921 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Senior Vice President acquired 1,256 shares (option exercise)
- 4 Open-market sale Senior Vice President sold 2,526 shares at an average $686.21 ($1,733,378)
- 4/A Open-market sale Senior Vice President sold 2,000 shares at $558.44 ($1,116,884)
- 3 Insider Initial Statement of Ownership
- 4 Gift Executive Vice President gave 522 shares (gift)
- 4 Open-market sale President & CEO sold 6,000 shares at an average $675.21 ($4,051,262)
- 4 Open-market sale Director sold 2,402 shares at $679.58 ($1,632,355)
- 4 Exercise or conversion Executive Vice President acquired 1,106 shares (option exercise)
- 4 Open-market sale Director sold 3,000 shares at an average $687.87 ($2,063,616)
- 4 Shares withheld for taxes Executive VP & CFO gave up 96 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 179 shares (to pay taxes)
- 4 Open-market sale Executive Vice President sold 538 shares at $703.00 ($378,214)
- 4 Open-market sale Senior Vice President sold 20,295 shares at an average $698.25 ($14,170,900)
- 4 Open-market sale Executive Vice President sold 6,999 shares at an average $691.62 ($4,840,670)
Page 14 of 74 · 1,467 filings